Oxford Nanopore Technologies plc (LON: ONT)
London
· Delayed Price · Currency is GBP · Price in GBX| Market Cap | 933.32M |
| Revenue (ttm) | 254.50M |
| Net Income (ttm) | -231.76M |
| Shares Out | 862.59M |
| EPS (ttm) | -0.28 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,035,527 |
| Open | 112.80 |
| Previous Close | 111.50 |
| Day's Range | 107.00 - 113.00 |
| 52-Week Range | 91.24 - 279.00 |
| Beta | 0.64 |
| Analysts | n/a |
| Price Target | 212.22 (+96.14%) |
| Earnings Date | Mar 6, 2024 |
About ONT
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company operates in Life Science Research Tools and Covid Testing segments. It offers MinION, a portable device for DNA and RNA; GridION, a flexible and self-contained benchtop nanopore sequencer to run and analyse up to five Min... [Read more]
Financial Performance
In 2023, ONT's revenue was 169.67 million, a decrease of -14.57% compared to the previous year's 198.60 million. Losses were -154.51 million, 69.7% more than in 2022.
Financial StatementsNews
RenovaroCube to acquire 100% ownership of Cyclomics
Renovaro strengthens its position in cancer diagnostics with the acquisition of Cyclomics, leveraging their partnerships with Oxford Nanopore and Nvidia.
Oxford Nanopore Technologies and SeqOne Partner to Support Interpretation of Nanopore Sequencing in Clinical Use
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and SeqOne, the leading AI...
Oxford Nanopore launches PromethION 2 Integrated into open early access
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies today announced the early access launch of its all-in-one desk top sequencing device, the PromethION 2 Integrated (P2i) to complete its P...
Oxford Nanopore Technologies plc (ONTTF) Full Year 2023 Earnings Call Transcript
Oxford Nanopore GAAP EPS of $19.00p, revenue of £169.7M
Oxford Nanopore: Ultra-Long Reads In A Short-Term Slump
Oxford Nanopore shares declined 33% due to slower growth, but positive prospects and unique product features offer potential. See more on ONTTF stock here.
Britain's Oxford Nanopore's shares sink after revenue warning
Shares in Britain's Oxford Nanopore dropped nearly 12% on Tuesday, after the sensing technology company issued a revenue warning, citing a slowdown in China and the Middle East, along with staggered p...
Oxford Nanopore sales hit by US semiconductor restrictions
Oxford Nanopore Technologies said it had seen disruption to its diagnostics businesses due to the US/China trade war and second-half sales growth was slower than expected in some areas Over 2023, rev...
Oxford Nanopore and WeNou Announce a Partnership to Develop and Commercialise the First Rapid and Portable Food Authenticity Sequencing Test to Detect Food Fraud
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies (Oxford Nanopore) and WeNou, a company providing innovative services based on DNA analysis for the food and feed sectors, today announce ...
Oxford Nanopore Technologies and Fabric Genomics Collaborate to Launch an Integrated Whole-Genome Sequencing Solution to Advance the Future of Paediatric Patient Care
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (Oxford Nanopore), the nanopore-sequencing company delivering unparalleled rich genomic data insights, and Fabric Genomics, the leadi...
Three Quick Facts: Coca Cola, Oxford Nanopore, BP
Tony Cross picks three things to know about the markets, featuring Coca Cola, Oxford Nanopore, BP
Oxford Nanopore Technologies and Saphetor Announce a New Partnership to Deliver Tertiary Analysis for Comprehensive Interpretation of Nanopore Sequencing
OXFORD, United Kingdom--(BUSINESS WIRE)-- #genomics--Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and Sap...
Oxford Nanopore gets £70m investment from French in-vitro diagnostics partner
Oxford Nanopore Technologies PLC (LSE:ONT) has secured a £70 million investment from French in-vitro diagnostics (IVD) company bioMérieux, in exchange for a 3.5% stake. Family-owned bioMérieux said it...
Mayo Clinic and Oxford Nanopore announce collaboration to advance precision medicine for cancer and genetic disorders
ROCHESTER, Minn. & OXFORD, England--(BUSINESS WIRE)--Mayo Clinic and Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, today unveile...
The University of Queensland and Oxford Nanopore Technologies Team up to Accelerate Research Into Quality Control Testing for mRNA Vaccines
OXFORD, England & BRISBANE, Australia--(BUSINESS WIRE)--Researchers at The University of Queensland are harnessing the latest sequencing technology developed by UK-based biotech Oxford Nanopore Techno...
NIH Center for Alzheimer's and Related Dementias publication shows comprehensive, high accuracy sequencing approach, using new Oxford Nanopore sequencing chemistry
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore sequencing technology has been used by a team led by researchers at the National Institutes of Health Center for Alzheimer's and Related Dementias (CA...
Oxford Nanopore tightens guidance, analysts remain sceptical
Oxford Nanopore Technologies PLC (LSE:ONT) analysts are still doubtful about the DNA sequencing company's medium-term guidance despite narrowing full-year revenue guidance and reporting better than ex...
Oxford Nanopore announces education collaboration with Cold Spring Harbor DNA Learning Center and launches pilot accessible sequencing education programme
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies (Oxford Nanopore) today announced the launch of “Education beta”, its pilot education programme and the first of its kind in the world de...
Oxford Nanopore Technologies and Geneyx Announce the First Scalable Software Solution to Advance the Future Clinical Use of Nanopore Sequencing
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and Geneyx, an AI platform...
Oxford Nanopore Technologies hails advances
Oxford Nanopore Technologies PLC (LSE:ONT) has announced significant breakthroughs in its nanopore sequencing technology at the annual London Calling conference. Delegates were told its "Q20+" chemist...
Oxford Nanopore and bioMérieux to Enter Into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics
OXFORD, England & MARCY-L'ETOILE, France--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (LSE: ONT) (“Oxford Nanopore”), the company delivering a new generation of nanopore-based molecular sensing ...
Oxford Nanopore Technologies reports narrowed loss as revenue jumps
Oxford Nanopore Technologies PLC (LSE:ONT) reported a solid increase in full-year revenue driven by growth in its Life Science Research Tools (LSRT) arm while loss for the period narrowed. For the yea...
Oxford Nanopore and PathoQuest announce the first steps in a strategic collaboration to bring the first GMP-accredited, nanopore-based biologics genetic characterisation test to market
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (Oxford Nanopore) and PathoQuest today announce the agreement of a MOU for a collaboration to commercialise a transformational Integr...
Oxford Nanopore and 4bases Announce Collaboration to Combine Nanopore Sequencing Devices and 4bases Kits to Support Rapid, High-accuracy Analyses in Human and Cancer Genetics, with a First Target of Same-day BRCA1 and BRCA2 Analysis
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (Oxford Nanopore) and 4bases, a Switzerland-based company, specialising in kits for sequencing and bioinformatic tools, today announc...
Oxford Nanopore Technologies and Cyclomics begin developer testing on non-invasive method for accurate and fast detection of molecules associated with cancer
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies and Dutch start-up Cyclomics today announced the ‘developer access' of a new research workflow: the world's first nanopore sequencing-bas...